Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]: Multiple Technology Appraisal (MTA)

Nicola Huxley; Louise Crathorne; Jo Varley-Campbell; Irina Tikhonova; Tristan Snowsill; Simon Briscoe; Jaime Peters; Mary Bond; Mark Napier; Martin Hoyle

Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]: Multiple Technology Appraisal (MTA)

Nicola Huxley, Louise Crathorne, Jo Varley-Campbell, Irina Tikhonova, Tristan Snowsill, Simon Briscoe, Jaime Peters, Mary Bond , Mark Napier, Martin Hoyle

Research output: Book/Report › Commissioned report

Original language	English
Publisher	University of Exeter
Number of pages	24
Publication status	Published - 2015
Externally published	Yes

Access to Document

https://www.nice.org.uk/guidance/TA439/documents/committee-papers

Cite this

Huxley, N., Crathorne, L., Varley-Campbell, J., Tikhonova, I., Snowsill, T., Briscoe, S., Peters, J., Bond , M., Napier, M., & Hoyle, M. (2015). Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]: Multiple Technology Appraisal (MTA). University of Exeter. https://www.nice.org.uk/guidance/TA439/documents/committee-papers

@book{9a124c27d56744afbfaa2de15dac87c3,

title = "Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]: Multiple Technology Appraisal (MTA)",

author = "Nicola Huxley and Louise Crathorne and Jo Varley-Campbell and Irina Tikhonova and Tristan Snowsill and Simon Briscoe and Jaime Peters and Mary Bond and Mark Napier and Martin Hoyle",

year = "2015",

language = "English",

publisher = "University of Exeter",

}

Huxley, N, Crathorne, L, Varley-Campbell, J, Tikhonova, I, Snowsill, T, Briscoe, S, Peters, J, Bond , M, Napier, M & Hoyle, M 2015, Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]: Multiple Technology Appraisal (MTA). University of Exeter. <https://www.nice.org.uk/guidance/TA439/documents/committee-papers>

TY - BOOK

T1 - Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]

T2 - Multiple Technology Appraisal (MTA)

AU - Huxley, Nicola

AU - Crathorne, Louise

AU - Varley-Campbell, Jo

AU - Tikhonova, Irina

AU - Snowsill, Tristan

AU - Briscoe, Simon

AU - Peters, Jaime

AU - Bond , Mary

AU - Napier, Mark

AU - Hoyle, Martin

PY - 2015

Y1 - 2015

M3 - Commissioned report

BT - Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]

PB - University of Exeter

ER -